Medtronic's OmniaSecure defib lead nets another FDA approval [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
lead, expanding its use to placement in the left bundle branch (LBB) area of the heart. Medtronic first commercially launched the lead in January 2026, designing it for use in conduction system pacing (CSP). It acts by monitoring and correcting a patient's heart rhythm via an implantable defibrillator, which delivers high-energy shocks during arrhythmia or fibrillation events. The US Food and Drug Administration (FDA) has approved OmniaSecure for use in the LBB area based on data from the LEADR study (NCT04863664), which found that the device delivered 100% defibrillation success at three months when placed in this region of the heart. OmniaSecure was also proven generally safe for use, with 2.1% of patients fitted with the lead experiencing major complications associated with the device. The FDA previously gave OmniaSecure the regulatory green light for use in the right ventricle back in April 2025. According to Medtronic, OmniaSecure has the smallest diameter of any defibril
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott completes acquisition of Exact SciencesPR Newswire
- Fidelity Stock Selector Mid Cap Fund Q4 2025 Scorecard: Buys, Sells, And Standouts [Seeking Alpha]Seeking Alpha
- Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- 2 Defensive Healthcare Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/23/26 - Form S-8
- 3/23/26 - Form 8-K
- 3/13/26 - Form ARS
- ABT's page on the SEC website